Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Zydus bags USFDA nod for acne gel Clindamycin Phosphate

Ruchika Sharma21 Sept 2023 11:30 AM IST

The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad, India.

Novartis opens new radioligand therapy manufacturing facility in California

BeiGene regains full rights from Novartis for Anti-PD-1 antibody Tevimbra

Ruchika Sharma20 Sept 2023 5:31 PM IST

Basel: BeiGene, Ltd., a global biotechnology company, has announced that it has entered into an agreement with Novartis to regain worldwide...

Govt may soon tweak PLI scheme for pharma

Ruchika Sharma20 Sept 2023 4:15 PM IST

New Delhi: The government may soon tweak the production-linked incentive scheme for pharmaceuticals, drones and textiles sectors to encourage...

Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA

Boston Scientific to acquire Relievant Medsystems

Ruchika Sharma20 Sept 2023 3:11 PM IST

Marlborough: Boston Scientific Corporation has announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately...

Low BP treatment: Caplin Steriles bags USFDA nod for Norepinephrine Bitartrate Injection

Ruchika Sharma20 Sept 2023 1:30 PM IST

Chennai: Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval by the United States...

Dr Reddy's Labs appoints Dr Alpna Hansraj Seth as Independent Additional Director

Ruchika Sharma20 Sept 2023 12:38 PM IST

Telangana: Dr Reddy's Labs has announced the appointment of Dr. Alpna Hansraj Seth as an Additional Director, categorized as Independent, on the Board...

Zydus Lifesciences gets USFDA EIR for formulation manufacturing facility at SEZ 2, Ahmedabad

Ruchika Sharma20 Sept 2023 11:19 AM IST

Ahmedabad: Zydus Lifesciences has announced that the company has received the Establishment Investigation Report (EIR) report from...

Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspection

USFDA issues 1 observation for Aurobindo Pharma arm AP facility

Ruchika Sharma20 Sept 2023 10:00 AM IST

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has issued a ‘Form 483’ with 1 observation at...

Torrent Pharma Plans Rs 12,500 Cr Fund Raise Through Secured NCD Issue

Torrent Pharma in discussions with Apollo to borrow up to USD 1 billion for Cipla bid: Sources

Ruchika Sharma19 Sept 2023 4:31 PM IST

Apollo is considering purchasing a small part of the Cipla founding family's stake but a final decision will depend on how talks progress with...

Good Bug raises Rs 29 crore in series A funding

Ruchika Sharma19 Sept 2023 3:30 PM IST

Mumbai: The Good Bug - India's gut health focused brand, has announced that it has raised $3.5M in series A funding led by Fireside Ventures. The...

Expanded age indication for GSK’s AREXVY

GSK HIV prevention drug gets European Commission authorisation

Ruchika Sharma19 Sept 2023 2:30 PM IST

London: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,...

HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuit

Gilead Kite declares positive trial results of T-cell Therapy Yescarta in Relapsed/Refractory Large B-cell Lymphoma

Ruchika Sharma19 Sept 2023 1:30 PM IST

Santa Monica: Kite, a Gilead Company has announced results from the Phase 2 ALYCANTE study, led and sponsored by the French collaborative group...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok